Free Trial

Allurion Technologies Q2 2024 Earnings Report

Allurion Technologies logo
$0.31 -0.01 (-1.65%)
(As of 05:44 PM ET)

Allurion Technologies EPS Results

Actual EPS
$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Allurion Technologies Revenue Results

Actual Revenue
$11.77 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Allurion Technologies Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry. 

Allurion Technologies Earnings Headlines

Allurion Technologies files $100M mixed securities shelf
DeFi Coin on Verge of Breakout!
The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.
See More Allurion Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Allurion Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Allurion Technologies and other key companies, straight to your email.

About Allurion Technologies

Allurion Technologies (NYSE:ALUR) focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

View Allurion Technologies Profile

More Earnings Resources from MarketBeat

Upcoming Earnings